Latest Ratios: P/E Ratio -3.2x · EV/EBITDA N/A · ROE -89.7%. (2006–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $101M | $293M | $267M | $133M | $232M | $530M | $346M | $61M | $131M | $131M | $115M |
| Enterprise Value | $80M | $273M | $250M | $106M | $160M | $411M | $311M | $52M | $113M | $116M | $102M |
| P/E Ratio → | -3.22 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 18.42 | 46.70 | 46.45 | 10.93 | 19.59 | 40.26 | 29.88 | 9.14 | 16.15 | 23.72 | 54.05 |
| P/B Ratio | 2.71 | 8.46 | 7.17 | 1.64 | 1.99 | 3.69 | 7.16 | 2.52 | 4.29 | 6.14 | 6.49 |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 43.49 | 43.37 | 8.77 | 13.54 | 31.21 | 26.90 | 7.87 | 14.02 | 21.03 | 47.88 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -16.9% | -16.9% | -84.5% | -14.4% | 19.3% | 22.0% | 18.2% | -66.1% | 21.8% | -12.2% | -54.7% |
| Operating Margin | -515.5% | -515.5% | -1285.4% | -431.2% | -356.8% | -303.7% | -165.2% | -398.3% | -270.1% | -349.5% | -871.3% |
| Net Profit Margin | -513.9% | -513.9% | -1277.9% | -413.5% | -344.4% | -306.7% | -155.0% | -396.9% | -270.3% | -354.5% | -904.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -89.7% | -89.7% | -124.5% | -50.8% | -31.3% | -42.1% | -49.5% | -96.8% | -84.4% | -100.4% | -113.9% |
| ROA | -81.2% | -81.2% | -117.1% | -45.9% | -29.0% | -40.2% | -44.4% | -83.3% | -70.6% | -79.8% | -91.9% |
| ROIC | -142.3% | -142.3% | -149.7% | -78.7% | -90.8% | -156.2% | -97.3% | -137.8% | -166.6% | -261.7% | -275.2% |
| ROCE | -89.3% | -89.3% | -125.1% | -52.8% | -32.3% | -41.3% | -50.9% | -94.4% | -84.3% | -98.4% | -103.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.03 | 0.01 | 0.00 | 0.01 | 0.01 | 0.03 | 0.09 | — | — | 0.08 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.58 | -0.47 | -0.32 | -0.61 | -0.83 | -0.72 | -0.35 | -0.57 | -0.70 | -0.74 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | — | — | — | — | -1130.58 | -80.11 | -27.97 |
Net cash position: cash ($21M) exceeds total debt ($1M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.56 | 5.56 | 12.65 | 7.96 | 5.97 | 33.00 | 14.56 | 7.24 | 5.86 | 3.91 | 4.12 |
| Quick Ratio | 5.12 | 5.12 | 10.37 | 6.23 | 5.23 | 30.07 | 12.58 | 5.07 | 4.30 | 3.20 | 3.52 |
| Cash Ratio | 4.33 | 4.33 | 8.61 | 5.09 | 4.75 | 28.92 | 11.65 | 4.03 | 3.69 | 2.74 | 3.29 |
| Asset Turnover | — | 0.16 | 0.15 | 0.14 | 0.09 | 0.09 | 0.22 | 0.23 | 0.23 | 0.21 | 0.10 |
| Inventory Turnover | 3.35 | 3.35 | 2.21 | 1.54 | 0.85 | 0.85 | 1.55 | 1.94 | 0.87 | 1.61 | 1.24 |
| Days Sales Outstanding | — | 147.67 | 144.82 | 126.44 | 132.44 | 62.17 | 43.77 | 88.75 | 34.83 | 97.02 | 17.73 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.0% | 0.0% | — | — | — | 1.9% | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.4% | 0.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.4% | 0.9% | 1.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $78M | $68M | $63M | $64M | $61M | $38M | $30M | $27M | $21M | $17M |
Includes 30+ ratios · 20 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying VUZI stock.
Vuzix Corp.'s current P/E ratio is -3.2x. The historical average is 41.7x.
Vuzix Corp.'s return on equity (ROE) is -89.7%. The historical average is -78.3%.
Based on historical data, Vuzix Corp. is trading at a P/E of -3.2x. Compare with industry peers and growth rates for a complete picture.
Vuzix Corp.'s current dividend yield is 0.02%.
Vuzix Corp. has -16.9% gross margin and -515.5% operating margin.
Key Metrics
Top Statement Risk
Structurally negative gross margins
Metrics are mathematically derived from official filings.
Returns Decaying on a Shrinking Capital Base
VUZI's ROIC has remained deeply negative in every one of the last ten quarters, printing -39.8% in 2026Q2 versus -13.5% in 2024Q1, per the company's reported quarterly ratios, indicating that no portion of the invested capital base is generating positive economic returns.
The -39.8% ROIC is only marginally better than the -45.7% trough in 2024Q4 but remains far worse than the -13.5% and -26.7% readings seen earlier in the series, which suggests improvement is episodic rather than trend-like. Critically, the ROA-ROE spread is narrow (ROE -23.4% vs. ROA -20.7% in 2026Q2) because debt is negligible at 0.02 D/E, meaning the loss on capital is driven by the asset base failing to generate margin, not by financial leverage amplifying it. Investors should monitor whether asset turnover (0.03x) can rise before interpreting any margin stabilization as a genuine return inflection.
Negative Gross Margins Distort Margin Signal
As reported in VUZI's quarterly filings, gross margin printed -58.0% in 2026Q2 after briefly turning positive at 16.7% in 2025Q4, meaning cost of goods sold exceeds revenue and rendering operating margin figures uninformative about underlying operating efficiency.
Because gross profit is negative, the reported operating margin of -7.0% is arithmetically flattered rather than reflecting operating discipline — the loss appears smaller at the operating line precisely because gross losses drag the starting point down while opex is spread over a $1.1M revenue base. The swing from -35.4% (2025Q3) to 16.7% (2025Q4) and back to -56.6% (2026Q1) suggests either inventory write-down timing or product-mix noise rather than a durable cost structure change. Net margin at -6.9% and FCF margin at -6.1% in 2026Q2 are therefore the only usable profitability yardsticks, and both remain negative.
Working Capital Cycle Trapped in a Long Tail
Based on VUZI's reported figures, the cash conversion cycle stood at 145 days in 2026Q2 — improved from the 964-day extreme of 2024Q2 — but DSO of 129 days against asset turnover of 0.03x indicates receivables are not converting into revenue at a pace commensurate with the capital tied up.
The CCC compression from 732 days (2024Q3) to 145 days (2026Q2) is largely a function of inventory being drawn down from the 561-day peak to 92 days, which reads more like liquidation of slow-moving stock than improved demand planning, given sequential revenue declines of -12% and -14%. DPO has swung between 9 and 102 days across the series without a discernible policy trend, implying payment timing is being managed to cash availability rather than negotiated supplier leverage. With asset turnover at just 0.03x, the balance sheet is carrying roughly 8.2x quarterly revenue in net PPE, a ratio that warrants investigation into whether the manufacturing footprint is right-sized for current volumes.
Book Value Premium Lacks Earnings Support
VUZI trades at approximately 30.98x trailing sales and 5.24x book value with a negative P/E of -5.57, per the market data provided, yet with an accumulated deficit of $414.6M the book-value denominator itself appears to reflect a capital base that has not earned its cost.
A 5.24x price-to-book multiple is unusual for a company with negative ROE of -23.4% and ROIC of -39.8%; historically such a premium is only justified when returns are expected to normalize, so the multiple appears to be pricing optionality on the smart-glasses platform rather than reported fundamentals. The P/S of ~31x sits above both MVIS (-0.25x P/E, 0.43x P/B) and WRAP (5.44x P/B), suggesting VUZI carries a valuation premium relative to its loss-making optical/photonics peer set that is not explained by relative margins or returns. EV/EBITDA and P/FCF are unavailable given negative EBITDA and FCF, which itself underscores that the valuation rests on revenue and asset narratives rather than cash-based metrics.
Cash Buffer Eroding but Still Covers Liabilities
As reported in VUZI's SEC filings, the current ratio declined from 13.16 in 2024Q3 to 5.70 in 2026Q2 with a quick ratio of 5.24, and cash of $17.3M now represents roughly 49% of a $35.2M total asset base, indicating liquidity is adequate in absolute terms but deteriorating.
The near-identical current and quick ratios confirm that inventory is a minor component of working capital, so the liquidity position is effectively a cash position — and the drawdown from $22.6M (2025Q3) to $17.3M implies quarterly consumption in the $1.5M–$2.0M range before any working-capital swings. Against roughly $4.1M in total liabilities and a debt-to-equity of 0.02, there is no near-term solvency pressure, but the low D/E appears to reflect limited lender appetite rather than a deliberate strategy, which may constrain refinancing flexibility. Investors should note that the erosion in the current ratio is driven by asset shrinkage as much as by burn, so the buffer's durability depends on whether revenue stabilizes.
P/E Misleads on an Unprofitable Manufacturer
The P/E ratio of -5.57 is the metric most commonly misapplied here, since negative earnings make it directionally meaningless and the magnitude reflects a shrinking loss rather than valuation support; net margin and FCF margin are the appropriate lenses for VUZI's manufacturing model.
For a consumer-electronics manufacturer whose gross margin is negative in eight of the last ten quarters, P/E invites a false read: a 'less negative' P/E can appear when losses widen relative to a falling share price, inverting the intuitive relationship between the ratio and business quality. The more informative pair is gross margin against asset turnover, since VUZI's economics hinge on whether COGS per unit can fall below price on scale — currently it cannot, at -58.0% gross margin on 0.03x turnover. EV/EBITDA, while unavailable here, would carry the same defect, as EBITDA is negative; free cash flow margin (-6.1% in 2026Q2) and the operating-expense-to-revenue ratio of approximately 6.4x are the metrics that would reveal any genuine inflection. This interpretation is an inference from the reported ratios and should be tested against product-level disclosure that the data provided does not contain.